01—Abstract
Summary
Summary of the 8-K filed May 22, 2025. Cited figures are marked; the original filing is the authoritative source.
Quest Diagnostics Inc. (DGX) filed an 8-K on May 22, 2025, reporting the voting results from its 2025 Annual Meeting of Stockholders held on May 15, 2025.
The filing confirms the election of all nominated directors to serve until the 2026 Annual Meeting, with overwhelming support from shareholders. Additionally, the advisory resolution on executive compensation was approved, reflecting shareholder confidence in the company's pay practices. The appointment of PricewaterhouseCoopers as the independent registered public accounting firm for 2025 also received strong ratification from stockholders.
Notably, a stockholder proposal seeking the ability to call a special meeting did not pass, indicating that current governance structures remain favored by the majority. Overall, the results suggest a stable shareholder base supportive of current management and board leadership.
02—Key points
Key Highlights
- All director nominees were overwhelmingly elected for terms expiring at the 2026 Annual Meeting.
- The advisory resolution to approve executive officer compensation received strong shareholder support.
- PricewaterhouseCoopers was ratified as the independent registered public accounting firm for 2025 with substantial approval.
- A stockholder proposal to allow for calling special meetings failed to gain majority support.
- Broker non-votes were a significant factor in the director elections, though not enough to prevent any nominee's success.
- The voting demonstrates broad shareholder alignment with the company's current board and compensation practices.
03—Questions
Frequently Asked Questions
Were all of Quest Diagnostics' nominated directors elected?
Yes, all director nominees presented at the 2025 Annual Meeting of Stockholders were elected by shareholders to serve until the 2026 Annual Meeting.
What was the outcome of the shareholder vote on executive compensation?
The advisory resolution to approve the executive officer compensation disclosed in the Company's 2025 Proxy Statement was approved by a significant majority of shareholders.
Was the company's choice of auditor ratified?
Yes, the ratification of PricewaterhouseCoopers as the Company’s independent registered public accounting firm for 2025 was approved by shareholders with strong support.
Did the proposal for shareholders to be able to call a special meeting pass?
No, the stockholder proposal regarding calling a special meeting of stockholders was not approved by the shareholders.
04—Continue